NCT02649231View on ClinicalTrials.gov

Ketamine for Reduction of Alcoholic Relapse

PHASE2CompletedINTERVENTIONAL
Enrollment

96

Participants

Timeline

Start Date

October 31, 2016

Primary Completion Date

February 29, 2020

Study Completion Date

February 29, 2020

Conditions
Primary Alcohol Use Disorder
Interventions
DRUG

Ketamine

0.8 mg/kg ketamine

DRUG

Placebo

0.9% saline

BEHAVIORAL

Psychological Therapy

Manualised relapse prevention based CBT

BEHAVIORAL

Alcohol Education

Simple education about alcohol effects

Trial Locations (2)

EX4 5DW

NIHR Exeter Clinical Research Facility, Exeter

NW1 2BU

NIHR UCLH Clinical Research Facility, London

All Listed Sponsors
lead

University College, London

OTHER

NCT02649231 - Ketamine for Reduction of Alcoholic Relapse | Biotech Hunter | Biotech Hunter